23 May 2013
Keywords: UK, NICE, Multiple sclerosis, Avonex, Betaferon, Rebif, Copaxone, Tysabri
Article | 03 December 2009
In 2002, the UK’s National Institute for Clinical Excellence (NICE) ruled that certain drugs for the treatment of multiple sclerosis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.